期刊文献+

Level of circulating PD-L1 expression in patients with advanced gastric cancer and its clinical implications 被引量:41

Level of circulating PD-L1 expression in patients with advanced gastric cancer and its clinical implications
下载PDF
导出
摘要 Objective:The programmed cell death-1 receptor/programmed cell death-1 ligand (PD-1/PD-L1) pathway plays a crucial role in tumor evasion from host immunity.This study was designed to evaluate the association between circulating PD-L1 expression and prognosis in patients with advanced gastric cancer.Methods:Totally 80 advanced gastric cancer patients and 40 health controls from Beijing Cancer Hospital were enrolled in the present study.Circulating PD-L1 expression was tested by enzymelinked immunosorbent assay (ELISA).The associations between the expression level of PD-L1 and clinicopathological features and prognosis were analyzed statistically.Results:Expression of PD-L1 in advanced gastric cancer patients was significandy up-regulated compared with health people (P=0.006).The expression of PD-L1 was significantly correlated with differentiation and lymph node metastasis (P=0.026 and P=0.041,respectively).Although we didn't find significant difference in all advanced gastric cancer patients with different PD-L1 expression,the adenocarcinoma patients with higher up-regulated PD-L1 expression had much better prognosis than low expression patients (65.6% vs.44.7%,P=0.028).Conclusions:PD-L1 was elevated in advance gastric cancer patients and may play an important role in tumor immune evasion and patients prognosis. Objective:The programmed cell death-1 receptor/programmed cell death-1 ligand (PD-1/PD-L1) pathway plays a crucial role in tumor evasion from host immunity.This study was designed to evaluate the association between circulating PD-L1 expression and prognosis in patients with advanced gastric cancer.Methods:Totally 80 advanced gastric cancer patients and 40 health controls from Beijing Cancer Hospital were enrolled in the present study.Circulating PD-L1 expression was tested by enzymelinked immunosorbent assay (ELISA).The associations between the expression level of PD-L1 and clinicopathological features and prognosis were analyzed statistically.Results:Expression of PD-L1 in advanced gastric cancer patients was significandy up-regulated compared with health people (P=0.006).The expression of PD-L1 was significantly correlated with differentiation and lymph node metastasis (P=0.026 and P=0.041,respectively).Although we didn't find significant difference in all advanced gastric cancer patients with different PD-L1 expression,the adenocarcinoma patients with higher up-regulated PD-L1 expression had much better prognosis than low expression patients (65.6% vs.44.7%,P=0.028).Conclusions:PD-L1 was elevated in advance gastric cancer patients and may play an important role in tumor immune evasion and patients prognosis.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2014年第1期104-111,共8页 中国癌症研究(英文版)
关键词 Programmed cell death-1 ligands (PD-L1) tumor immunity advanced gastric cancer enzyme-linked immunosorbent assay (ELISA) Programmed cell death-1 ligands (PD-L1) tumor immunity advanced gastric cancer enzyme-linked immunosorbent assay (ELISA)
  • 相关文献

参考文献2

二级参考文献15

  • 1Jian-Ming Sheng, Wen-He Zhao, Fu-Sheng Wu, Zhi-Min Ma, Yi-Zheng Feng, Xing-Ren Zhou and Li-Song Teng Department of Oncological Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003 , China.The Chinese classification system compared with TNM staging in prognosis of patients with primary hepatic carcinoma after resection[J].Hepatobiliary & Pancreatic Diseases International,2005,4(4):561-564. 被引量:9
  • 2白春学,张新.肺癌的治疗现状[J].中华结核和呼吸杂志,2006,29(3):146-148. 被引量:61
  • 3Jemal A,Siegel R,Xu J,et al. Cancer statistics,2010. CA Cancer J Clin,2010,60:277-300.
  • 4Wang L,Ma Q,Chen X,et al.Clinical significance of B7-H1 and B7-1 expressions in pancreatic carcinoma. World J Surg,2010,34:1059-1065.
  • 5Cao Y,Zhang L,Kamimura Y,et al. B7-H1 overexpression regulates epithelial-mesenchymal transition and accelerates carcinogenesis in skin.Cancer Res,2011,71:1235-1243.
  • 6Qin W,Hongya W,Yongjing C,et al.Increased OX40 and soluble OX40 ligands in children with Henoch-Schonlein purpura:association with renal involvement. Pediatr Allergy Immunol,2011,22:54-59.
  • 7Wang Q,Chen Y,Xie F,et al.Development of a sandwich ELISA for evaluating soluble OX40L (CD252) in human sera of different ages or with Graves' disease. Cytokine,2006,36:23-28.
  • 8Tousoulis D,Androulakis E, Papageorgiou N, et al. From atherosclerosis to acute coronary syndromes:the role of soluble CD40 ligand.Trends Cardiovasc Med,2010,20:153-164.
  • 9Simone R,Brizzolara R,Chiappori A,et al.A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury. Int Immunol,2009,21:1037-1045.
  • 10Chen Y,Wang Q,Shi B,et al.Development of a sandwich ELISA for evaluating soluble PD-L1 (CD274) in human sera of different ages as well as supernatants of PD-L1 + cell lines.Cytokine,2011,56:231-238.

共引文献46

同被引文献137

引证文献41

二级引证文献232

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部